The Future of Medicine Shaped
by Cutting-Edge Cell Design Technology
The Research Institute for Cell Design Medical Science (RICeD) aims to become an international research and development center that successively creates seeds for the next-generation cell and gene therapies, through innovative cell design technologies, which are core strength of Yamaguchi University. RICeD also aims to promote the practical application of cutting-edge immunotherapy and genome medicine based on our innovative technologies, to develop treatments for intractable diseases such as cancer and genetic diseases, and to apply and verify these innovative therapies in companion animals. By creating an active cycle in which knowledge gained in humans and companion animals is fed back to each other, RICeD will endeavor to form a drug discovery ecosystem through the social implementation of the created technologies, contribute to local communities and foster human resources through the creation of industries, and extend the healthy lifespan of both humans and companion animals.
- ALL
- News
- Thesis
- Recruiting
News
2025.01.21
*Notice* We are challenging crowdfunding!
News
2024.12.18
*Report* “The Frontiers of Regenerative and Cellular Medicine: Changing the Future of Medicine” was held as an open-house event.
News
2024.12.16
*Report* Seminar on Medical Information Systems Research was held.
News
2024.12.13
*Report* FOCS Project Selected
News
2024.11.11
*Information* Seminar of the Division of Medical Informatics and Systems Research will be held on December 13.
News
2024.11.11
*Information* Open-house event “The Frontiers of Regenerative and Cellular Medicine: Changing the Future of Medicine” will be held on December 17.
News
2024.11.08
*Information* Symposium on Multi-level Systems Medicine “New Challenges to Intractable Diseases by Artificial Intelligence and Systems Medicine” will be held on November 30.
News
2024.10.14
*Announcement* We exhibited at BioJapan2024.
Thesis
2025.01.16
Concomitant Administration of Dantrolene is Sufficient to Protect Against Doxorubicin-Induced Cardiomyopathy
Thesis
2024.12.13
Establishment of a novel amyotrophic lateral sclerosis patient (TARDBP N345K/+)-derived brain microvascular endothelial cell model reveals defective Wnt/β-catenin signaling: investigating diffusion barrier dysfunction and immune cell interaction.
Thesis
2024.10.30
Kinetics of pro- and anti-inflammatory spike-specific cellular immune responses in long-term care facility residents after COVID-19 mRNA primary and booster vaccination: a prospective longitudinal study in Japan.
Thesis
2024.10.08
Calcineurin-mediated dephosphorylation stabilizes E2F1 protein by suppressing binding of the FBXW7 ubiquitin ligase subunit
Thesis
2024.09.28
Establishment of Noninvasive Prediction Models for the Diagnosis of Uterine Leiomyoma Subtypes
Thesis
2024.09.19
Therapeutic efficacy of IL-7/CCL19-expressing CAR-T cells in intractable solid tumor models of glioblastoma and pancreatic cancer
Thesis
2024.09.18
Endogenous retrovirus ERV-DC8 highly integrated in domestic cat populations is a replication-competent provirus
Thesis
2024.07.12
Nuclear actin assembly is an integral part of decidualization in human endometrial stromal cells
The article could not be found.
News
2025.01.21
*Notice* We are challenging crowdfunding!
Thesis
2025.01.16
Concomitant Administration of Dantrolene is Sufficient to Protect Against Doxorubicin-Induced Cardiomyopathy
News
2024.12.18
*Report* “The Frontiers of Regenerative and Cellular Medicine: Changing the Future of Medicine” was held as an open-house event.
News
2024.12.16
*Report* Seminar on Medical Information Systems Research was held.
News
2024.12.13
*Report* FOCS Project Selected
Thesis
2024.12.13
Establishment of a novel amyotrophic lateral sclerosis patient (TARDBP N345K/+)-derived brain microvascular endothelial cell model reveals defective Wnt/β-catenin signaling: investigating diffusion barrier dysfunction and immune cell interaction.
News
2024.11.11
*Information* Seminar of the Division of Medical Informatics and Systems Research will be held on December 13.
News
2024.11.11
*Information* Open-house event “The Frontiers of Regenerative and Cellular Medicine: Changing the Future of Medicine” will be held on December 17.
About RICeD
Request for Donations to RICeD
We are promoting the development of cutting-edge cancer immunotherapy to cure many patients.
We are also working to extend the healthy lifespan of both humans and companion animals by applying the world’s first genome editing technology to the treatment of genetic diseases in companion animals and applying the results to human medicine,
We are also working to extend the healthy lifespan of both humans and companion animals by applying the results of our research to human medicine.We sincerely ask for your support to achieve these goals and to continue to promote the practical application of our research results in society.
ー Follow us! ー